Health
Calculate the Padua Prediction Score to stratify venous thromboembolism (VTE) risk in hospitalized medical (non-surgical) patients. 11 categories: 3 points each (active cancer metastatic or chemo/radiation ≤6 months, previous VTE, reduced mobility ≥3 days, known thrombophilia); 2 points (recent ≤1 month trauma and/or surgery); 1 point each (age ≥70, heart and/or respiratory failure, acute MI or ischemic stroke, acute infection and/or rheumatologic disorder, obesity BMI ≥30, ongoing hormonal treatment). Interpretation: <4 low risk (VTE ~0.3% — case-by-case prophylaxis); ≥4 high risk (VTE ~11% without prophylaxis — recommend pharmacologic prophylaxis, e.g., LMWH). Derived from Barbar et al. 2010. Not medical advice.
Call this tool from your code in three languages.
curl -X POST 'http://127.0.0.1:3003/en/api/tools/padua-score' \
-H 'Content-Type: application/json' \
-d '{"cancer":true,"prevVte":false,"reducedMobility":true,"thrombophilia":false,"recentTraumaSurgery":false,"elderly":false,"heartRespFailure":true,"miStroke":false,"infectionRheum":false,"obesity":true,"hormonal":false}'Send a POST request with your inputs as JSON. File parameters require a separate upload first.
POST http://127.0.0.1:3003/en/api/tools/padua-score| Name | Type | Required | Description |
|---|---|---|---|
| cancer | checkbox | No | Local/distant metastasis and/or chemo or radiation within 6 months. +3. |
| prevVte | checkbox | No | Previous DVT or PE (excluding superficial vein thrombosis). +3. |
| reducedMobility | checkbox | No | Bedridden or greatly reduced mobility for ≥ 3 days. +3. |
| thrombophilia | checkbox | No | Known thrombophilic condition (e.g., antithrombin deficiency, Factor V Leiden, antiphospholipid syndrome). +3. |
| recentTraumaSurgery | checkbox |
Add this tool to your Model Context Protocol server so AI agents can list and call it.
Add this block to your MCP client configuration:
{
"mcpServers": {
"elysiatools-padua-score": {
"name": "padua-score",
"description": "Calculate the Padua Prediction Score to stratify venous thromboembolism (VTE) risk in hospitalized medical (non-surgical) patients. 11 categories: 3 points each (active cancer metastatic or chemo/radiation ≤6 months, previous VTE, reduced mobility ≥3 days, known thrombophilia); 2 points (recent ≤1 month trauma and/or surgery); 1 point each (age ≥70, heart and/or respiratory failure, acute MI or ischemic stroke, acute infection and/or rheumatologic disorder, obesity BMI ≥30, ongoing hormonal treatment). Interpretation: <4 low risk (VTE ~0.3% — case-by-case prophylaxis); ≥4 high risk (VTE ~11% without prophylaxis — recommend pharmacologic prophylaxis, e.g., LMWH). Derived from Barbar et al. 2010. Not medical advice.",
"baseUrl": "http://127.0.0.1:3003/mcp/sse?toolId=padua-score",
"command": "",
"args": [],
"env": {},
"isActive": true,
"type": "sse"
}
}
}After connecting to the SSE endpoint, list the exposed tools:
{
"jsonrpc": "2.0",
"id": 1,
"method": "tools/list"
}Invoke the tool by its id, passing arguments built from its parameters:
{
"jsonrpc": "2.0",
"id": 2,
"method": "tools/call",
"params": {
"name": "padua-score",
"arguments": {
"cancer": true,
"prevVte": false,
"reducedMobility": true,
"thrombophilia": false,
"recentTraumaSurgery": false,
"elderly": false,
"heartRespFailure": true,
"miStroke": false,
"infectionRheum": false,
"obesity": true,
"hormonal": false
}
}
}| No |
| Trauma and/or surgery within the past month. +2. |
| elderly | checkbox | No | Age 70 years or older. +1. |
| heartRespFailure | checkbox | No | Heart failure and/or respiratory failure. +1. |
| miStroke | checkbox | No | Acute myocardial infarction or ischemic stroke. +1. |
| infectionRheum | checkbox | No | Acute infection and/or rheumatologic disorder. +1. |
| obesity | checkbox | No | Body mass index ≥ 30 kg/m². +1. |
| hormonal | checkbox | No | Ongoing hormonal treatment (e.g., oral contraceptives, HRT). +1. |
JSON result
{
"key": {...},
"metadata": {
"key": "value"
},
"error": "Error message (optional)",
"message": "Notification message (optional)"
}Questions or issues? Contact [email protected]